Wells Fargo & Company Heart Test Laboratories, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Heart Test Laboratories, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 453 shares of HSCS stock, worth $1,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
453
Previous 64
607.81%
Holding current value
$1,997
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HSCS
# of Institutions
24Shares Held
1.55MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA192KShares$844,6950.0% of portfolio
-
Tradition Wealth Management, LLC180KShares$795,8500.0% of portfolio
-
Northern Trust Corp Chicago, IL165KShares$729,2940.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il123KShares$542,8090.0% of portfolio
-
Hrt Financial LP New York, NY122KShares$540,0700.0% of portfolio
About Heart Test Laboratories, Inc.
- Ticker HSCS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,202,550
- Market Cap $36.2M
- Description
- Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...